Additionally, experiments in our study only proved that the expression levels of SUMO1P3 could influence the oncogenicity of HCC cells, and whether the overexpression of SUMO1P3 could endow normal hepatic cells with oncogenic ability remained unclear. The gene discussed is SUMO1P3; the disease is hepatocellular carcinoma.